Related literature
There are many useful pharmacological properties of benzo [c] phenanthridine derivatives (Clement et al., 2005) . For their antitumour activity, see: Stermitz et al. (1973 Stermitz et al. ( , 1975 Fang et al. (1993) ; Suzuki et al. (1992) ; Kanzawa et al. (1997) Table 1 Hydrogen-bond geometry (Å , ).
Cg1, Cg2 and Cg3 are the centroids of the C1-C6, C47-C52 and C17-C22 rings, respectively. its structure is reported here.
D-HÁ
The asymmetric unit of (I) contains two independent molecules ( 
Experimental
To 15 ml dry dichloromethane, 11-(4-chlorophenyl)-6-amino-11,12-2H-benzo[c]phenanthridine (0.36 g, 1.0 mmol, prepared according to the reported procedure (Zhang et al., 2008) ) and triethylamine (0.18 ml, 1.3 mmol) were added. The mixture was stirred for 30 min at room temperature. A solution of benzoyl chloride (0.17 g, 1.2 mmol) in 3 ml of dry dichloromethane was added dropwise to the above mixture with stirring at room temperature. After completion of the reaction (monitored on TLC), the solvent was removed under vacuum, and the residue was dissolved in 30 ml of water and extracted with dichloromethane. The combined organic phase was dried over sodium sulfate and concentrated under reduced pressure. The resulting crude product was recrystallized from petroleum ether and ethyl acetate. Single crystals of (I) suitable for X-ray diffraction were obtained after slow evaporation of the mother liquor.
Refinement
All H atoms were placed in calculated positions, with C-H = 0.93, 0.97 or 0.98 Å and N-H = 0.86 Å, and included in the final cycles of refinement using a riding model, with U iso (H) = 1.2U eq (C).
Figures Fig. 1 . The asymmetric unit of the title compound, (I), with displacement ellipsoids drawn at the 30% probability level. 
